Skip to main content
Erschienen in: Internal and Emergency Medicine 6/2019

11.05.2019 | IM - COMMENTARY

The two congested failing giants: heart and liver

verfasst von: Piero Portincasa

Erschienen in: Internal and Emergency Medicine | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Excerpt

Liver disease related to the heart includes acute liver injury due to the heart, i.e., myocardial infarction, sustained arrhythmia resulting in passive congestion of the liver, chronic passive liver congestion, and “cardiac cirrhosis” [1]. Causes of congestive heart failure appear in Fig. 1 [1]. Congestive heart failure occurs when patients with advanced heart failure experience persistent and severe symptoms interfering with daily life. Advanced congestive heart failure manifests with typical symptoms (Fig. 1) and, by definition, manifestations occur despite maximum evidence-based medical therapy of heart failure, and reversible causes addressed [2, 3]. Advanced heart failure has major socio-economic burden; patients experience recurrent hospitalization, and the risk of mortality increases with the frequency of re-hospitalization [4, 5]. We reported that addressing an intensive outpatient management program to patients with chronic heart failure has beneficial long-term effects on clinical parameters, and decreases hospitalization [6].
Literatur
1.
Zurück zum Zitat Ford RM, Book W, Spivey JR (2015) Liver disease related to the heart. Transplant Rev 29(1):33–37 (Orlando) CrossRef Ford RM, Book W, Spivey JR (2015) Liver disease related to the heart. Transplant Rev 29(1):33–37 (Orlando) CrossRef
2.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128(16):1810–1852PubMedCrossRef Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128(16):1810–1852PubMedCrossRef
3.
Zurück zum Zitat Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH, Potena L, Ross HJ, Taylor DO, Verschuuren EA, Zuckermann A, International Society for Heart Lung Transplantation Infectious Diseases C, International Society for Heart Lung Transplantation Pediatric Transplantation C, International Society for Heart Lung Transplantation Heart F, Transplantation C (2016) The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transpl 35(1):1–23CrossRef Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH, Potena L, Ross HJ, Taylor DO, Verschuuren EA, Zuckermann A, International Society for Heart Lung Transplantation Infectious Diseases C, International Society for Heart Lung Transplantation Pediatric Transplantation C, International Society for Heart Lung Transplantation Heart F, Transplantation C (2016) The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transpl 35(1):1–23CrossRef
4.
Zurück zum Zitat Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA, Candesartan in Heart failure: Assessment of Reduction in M, morbidity I (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116(13):1482–1487PubMedCrossRef Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA, Candesartan in Heart failure: Assessment of Reduction in M, morbidity I (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116(13):1482–1487PubMedCrossRef
5.
Zurück zum Zitat Setoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154(2):260–266PubMedCrossRef Setoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154(2):260–266PubMedCrossRef
8.
Zurück zum Zitat Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC (2010) Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail 3(1):59–64PubMedCrossRef Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC (2010) Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail 3(1):59–64PubMedCrossRef
9.
Zurück zum Zitat Myers RP, Cerini R, Sayegh R, Moreau R, Degott C, Lebrec D, Lee SS (2003) Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology 37(2):393–400PubMedCrossRef Myers RP, Cerini R, Sayegh R, Moreau R, Degott C, Lebrec D, Lee SS (2003) Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology 37(2):393–400PubMedCrossRef
10.
Zurück zum Zitat Hilscher M, Sanchez W (2016) Congestive hepatopathy. Clin Liver Dis 8(3):68–71CrossRef Hilscher M, Sanchez W (2016) Congestive hepatopathy. Clin Liver Dis 8(3):68–71CrossRef
11.
12.
Zurück zum Zitat Lefkowitch JH, Mendez L (1986) Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2(3):313–327PubMedCrossRef Lefkowitch JH, Mendez L (1986) Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 2(3):313–327PubMedCrossRef
13.
Zurück zum Zitat Arcidi JM Jr, Moore GW, Hutchins G (1981) Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 104(2):159PubMedPubMedCentral Arcidi JM Jr, Moore GW, Hutchins G (1981) Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol 104(2):159PubMedPubMedCentral
14.
Zurück zum Zitat Dai DF, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM (2014) Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. Mod Pathol 27(12):1552–1558PubMedCrossRef Dai DF, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM (2014) Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. Mod Pathol 27(12):1552–1558PubMedCrossRef
15.
Zurück zum Zitat Koehne de Gonzalez AK, Lefkowitch JH (2017) Heart disease and the liver: pathologic evaluation. Gastroenterol Clin N Am 46(2):421–435CrossRef Koehne de Gonzalez AK, Lefkowitch JH (2017) Heart disease and the liver: pathologic evaluation. Gastroenterol Clin N Am 46(2):421–435CrossRef
16.
17.
Zurück zum Zitat Weisberg IS, Jacobson IM (2011) Cardiovascular diseases and the liver. Clin Liver Dis 15(1):1–20PubMedCrossRef Weisberg IS, Jacobson IM (2011) Cardiovascular diseases and the liver. Clin Liver Dis 15(1):1–20PubMedCrossRef
18.
Zurück zum Zitat Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate IICI (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120(23):2352–2357PubMedCrossRef Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate IICI (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120(23):2352–2357PubMedCrossRef
19.
Zurück zum Zitat Dichtl W, Vogel W, Dunst KM, Grander W, Alber HF, Frick M, Antretter H, Laufer G, Pachinger O, Polzl G (2005) Cardiac hepatopathy before and after heart transplantation. Transpl Int 18(6):697–702PubMedCrossRef Dichtl W, Vogel W, Dunst KM, Grander W, Alber HF, Frick M, Antretter H, Laufer G, Pachinger O, Polzl G (2005) Cardiac hepatopathy before and after heart transplantation. Transpl Int 18(6):697–702PubMedCrossRef
20.
Zurück zum Zitat Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K, Khawaja T, Farr M, Takayama H, Naka Y, Mancini DM, Schulze PC (2012) Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transpl 31(6):591–600CrossRef Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K, Khawaja T, Farr M, Takayama H, Naka Y, Mancini DM, Schulze PC (2012) Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transpl 31(6):591–600CrossRef
21.
Zurück zum Zitat Kisloff B, Schaffer G (1976) Fulminant hepatic failure secondary to congestive heart failure. Am J Dig Dis 21(10):895–900PubMedCrossRef Kisloff B, Schaffer G (1976) Fulminant hepatic failure secondary to congestive heart failure. Am J Dig Dis 21(10):895–900PubMedCrossRef
22.
Zurück zum Zitat Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y (2017) Liver stiffness assessed by fibrosis-4 index predicts mortality in patients with heart failure. Open Heart 4(1):e000598PubMedPubMedCentralCrossRef Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y (2017) Liver stiffness assessed by fibrosis-4 index predicts mortality in patients with heart failure. Open Heart 4(1):e000598PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Colli A, Pozzoni P, Berzuini A, Gerosa A, Canovi C, Molteni EE, Barbarini M, Bonino F, Prati D (2010) Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology 257(3):872–878PubMedCrossRef Colli A, Pozzoni P, Berzuini A, Gerosa A, Canovi C, Molteni EE, Barbarini M, Bonino F, Prati D (2010) Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology 257(3):872–878PubMedCrossRef
24.
Zurück zum Zitat Barr RG, Ferraioli G, Palmeri ML, Goodman ZD, Garcia-Tsao G, Rubin J, Garra B, Myers RP, Wilson SR, Rubens D, Levine D (2015) Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology 276(3):845–861PubMedCrossRef Barr RG, Ferraioli G, Palmeri ML, Goodman ZD, Garcia-Tsao G, Rubin J, Garra B, Myers RP, Wilson SR, Rubens D, Levine D (2015) Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology 276(3):845–861PubMedCrossRef
25.
Zurück zum Zitat Chundru S, Kalb B, Arif-Tiwari H, Sharma P, Costello J, Martin DR (2013) MRI of diffuse liver disease: the common and uncommon etiologies. Diagn Interv Radiol 19(6):479–487PubMed Chundru S, Kalb B, Arif-Tiwari H, Sharma P, Costello J, Martin DR (2013) MRI of diffuse liver disease: the common and uncommon etiologies. Diagn Interv Radiol 19(6):479–487PubMed
26.
Zurück zum Zitat Persico M, Palmentieri B, Vecchione R, Torella R (2002) Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. Am J Gastroenterol 97(2):491–492PubMedCrossRef Persico M, Palmentieri B, Vecchione R, Torella R (2002) Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy. Am J Gastroenterol 97(2):491–492PubMedCrossRef
27.
Zurück zum Zitat Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97(10):2614–2618PubMedCrossRef Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97(10):2614–2618PubMedCrossRef
28.
Zurück zum Zitat Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, Investigators C (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail 11(2):170–177PubMedPubMedCentralCrossRef Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, Investigators C (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail 11(2):170–177PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Cohen JA, Kaplan MM (1978) Left-sided heart failure presenting as hepatitis. Gastroenterology 74(3):583–587PubMedCrossRef Cohen JA, Kaplan MM (1978) Left-sided heart failure presenting as hepatitis. Gastroenterology 74(3):583–587PubMedCrossRef
30.
Zurück zum Zitat Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr (2010) Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 160(6):1149–1155PubMedCrossRef Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, Januzzi JL Jr (2010) Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 160(6):1149–1155PubMedCrossRef
31.
Zurück zum Zitat Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155(5):883–889PubMedCrossRef Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155(5):883–889PubMedCrossRef
32.
Zurück zum Zitat Arques S, Ambrosi P (2011) Human serum albumin in the clinical syndrome of heart failure. J Card Fail 17(6):451–458PubMedCrossRef Arques S, Ambrosi P (2011) Human serum albumin in the clinical syndrome of heart failure. J Card Fail 17(6):451–458PubMedCrossRef
33.
Zurück zum Zitat Giallourakis CC, Rosenberg PM, Friedman LS (2002) The liver in heart failure. Clin Liver Dis 6(4):947–967PubMedCrossRef Giallourakis CC, Rosenberg PM, Friedman LS (2002) The liver in heart failure. Clin Liver Dis 6(4):947–967PubMedCrossRef
34.
Zurück zum Zitat Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140(1):111–120PubMedCrossRef Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140(1):111–120PubMedCrossRef
Metadaten
Titel
The two congested failing giants: heart and liver
verfasst von
Piero Portincasa
Publikationsdatum
11.05.2019
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 6/2019
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02103-6

Weitere Artikel der Ausgabe 6/2019

Internal and Emergency Medicine 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.